Brokerages Set Entrada Therapeutics, Inc. (NASDAQ:TRDA) Target Price at $18.50
Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six brokerages that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, three have issued a buy recommendation and […]
4 Apr 05:12 · The Markets Daily